Pacific Biosciences of California Inc
NASDAQ:PACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
I
|
InterCard Informationssysteme AG
F:II8
|
DE |
|
G
|
GPS Alliance Holdings Ltd
ASX:GPS
|
SG |
|
Tier 1 Technology SA
MAD:TR1
|
ES |
|
Indofood Sukses Makmur Tbk PT
IDX:INDF
|
ID |
|
S
|
Smart Digital Group Ltd
NASDAQ:SDM
|
SG |
|
Premier Health of America Inc
XTSX:PHA
|
CA |
|
S
|
Sieu Thanh Joint Stock Corp
VN:ST8
|
VN |
|
I
|
Imperial Oil Ltd
F:IMP
|
CA |
Wall St Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for PACB is 2.34 USD with a low forecast of 1.26 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
2.34
USD
According to Wall Street analysts, the average 1-year price target for PACB is 2.34 USD with a low forecast of 1.26 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 28%.
